Ventana Medical receives FDA approval for new breast cancer genetic test

Links shared publicly online about this topic.

  • 218
    total visits

Ventana Medical receives FDA approval for new breast cancer genetic test

news-medical.net

The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin, a commonly used breast cancer treatment.

View full resource at news-medical.net

Tags: Genetic, Cancer, Breast Cancer, Diet and Nutrition, Lab Test, Women's Health, FDA, Medical

  • Share

Most Recently Shared on June 15, 2011 at 6:36 am By:

NewsMedical News-Medical.Net

Ventana Medical receives FDA approval for new breast cancer genetic test: The U.S. Food and Drug Administration ... http://bit.ly/mrQ99k

11 months ago...

Inform Dual ISH HER2 Test Approved for Breast Cancer - ONA

oncologynurseadvisor.com — “The FDA has approved Inform Dual ISH from Ventana Medical Systems, a genetic test to help determine if women with breast cancer are HER2-positive and therefore candidates to receive Herceptin (trastuzumab; Genentech), a HER2 inhibitor.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 14, 2011 at 9:32 pm By:

Advertisement